Gene Query: PHYH

Dataset Description Geneva Score
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 141.03
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 141.03
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 70.86
Effect of CHKA knockdown on C4-2 cell transcriptome 35.27
ARID1A regulates condensin II distribution and chromosomal partition 28.67
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 28.67
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 25.56
Seletive inhibition of CDK9 in DLBCL cell lines 25.51
RNA-seq data from human lymphoma cell lines 23.41
ChIP-seq and RNA-seq from human lymphoma cell lines 23.41
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 20.49
The effect of insulin on mRNA transcription of human pluripotent stem cells 15.34
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 14.89
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 14.53
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 14.34
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 14.34
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 14.22
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 14.14
Epigenomic landscape during organ formation in human early embryos 14.12
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 14.1
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 13.74
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 13.68
Gene expression analysis of immortalized human liver progenitor-like cells in culture 13.42
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 13.16
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 12.81
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 12.73
Gene expression analysis of human liver progenitor-like cells in culture 12.68
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 12.53
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 12.53
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 12.27
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 12.27
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 11.85
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 11.76
Single-nucleotide-resolution mapping of HBV promoters using CAGE 11.64
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 11.23
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 10.99
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 10.85
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 10.73
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 10.7
CDK4/6 inhibitor resistance in prostate cancer 10.6
Chromatin landscape of human visceral and subcutaneous adipocytes 10.44
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 10.36
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 10.35
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 10.3
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 10.25
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 10.24
HEK293 TFAM Knockout Expression Study 9.75
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 9.48
Cellular response to hepatitis E virus (HEV) infection 9.25
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 9.18
Role for citron kinase in prostate cancer growth 9.02
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 8.93
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 8.88
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 8.8
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 8.8
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 8.75
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 8.67
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 8.67
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 8.65
WRN knockout effects upon gene expression in SW48 and OVK18 8.5
Paxillin regulates genomic networks in prostate cancer [LNCaP] 8.48
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 8.39
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 8.29
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 8.17
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 8.06
Small-molecule targeting of brachyury transcription factor addiction in chordoma 7.97
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 7.9
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 7.87
Gene expression profile difference among renal location in a stone former 7.82
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 7.79
RNA sequencing of BT142 and TS603 cell lines 7.79
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 7.63
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 7.63
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 7.3
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 7.21
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 7.16
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 6.96
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 6.94
Androgen Receptor-regulated genes in prostate cancer cells 6.79
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 6.79
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 6.72
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 6.72
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 6.67
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 6.48
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 6.48
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 6.34
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 6.33
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 6.32
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 6.26
AR-independent prostate cancer is sustained through FGF signaling 6.15
RNA-seq analyses of human prostate cancer cells 6.12
HNRNPM-regulated splicing dependencies in prostate cancer 6.02
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 6.02
RNA-seq of young and quiescent MRC-5 human fibroblasts 5.99
Transcription control by the ENL YEATS domain in acute leukemia 5.93
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 5.93
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 5.86
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 5.8
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 5.79
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 5.74
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 5.74
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 5.67
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 5.67
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 5.57
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 5.56
MOF acetyl transferase regulates transcription and respiration in mitochondria 5.55
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 5.41
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 5.41
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 5.37
A549 cells and MSR-A549 cells 5.33
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 5.33
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 5.33
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 5.32
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 5.31
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 5.31
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 5.27
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 5.27
Tumor exosome integrins determine organotropic metastasis 5.26
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 5.05
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 5.04
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 5.02
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 5.0
Stem and effector CD8 T-cells from human cancers 4.96
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 4.96
Transcriptome-wide response to synthetic chromatin protein PcTF 4.9
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 4.9
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 4.89
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 4.79
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 4.79
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 4.7
4.69
T47D RNA-seq and ChrRNA-seq data 4.64
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 4.64
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 4.59
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 4.58
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 4.57
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 4.56
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 4.47
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 4.45
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 4.45
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 4.43
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 4.43
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 4.41
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 4.36
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 4.34
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 4.34
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 4.33
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 4.27
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 4.23
Postnatal lipids drive hepatocyte maturation 4.23
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 4.23
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 4.21
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 4.18
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 4.17
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 4.13
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 4.13
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 4.11
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 4.09
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 4.02
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 4.01
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 3.98
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 3.98
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 3.95
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 3.86
The regulartory role of ZCCHC24 in splicing machinery 3.84
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 3.83
RNA-sequencing of human liver tissue 3.81
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 3.81
RNA-seq differential expression studies: more sequence, or more replication? 3.79
Transcriptome of human white and brown adipose tissue biopsies 3.77
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 3.76
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 3.7
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 3.7
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 3.7
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 3.68
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 3.67
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 3.67
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 3.66
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 3.64
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 3.58
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 3.57
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 3.57
The effect of PPARG inhibition on human angiomyolipoma cells 3.56
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 3.56
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 3.55
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 3.53
HNRNPL and its RNA Targets in Prostate Cancer 3.53
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 3.53
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 3.53
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 3.53
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 3.53
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 3.52
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 3.52
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 3.52
Identification of expressed and conserved human non-coding RNAs 3.52
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 3.5
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 3.49
Neonatal and adult human testis defined at the single-cell level 3.48
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 3.47
Genome-wide functional assessment of enhancer activities in the human genome 3.47
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 3.46
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 3.43
Nutritional control of protein translation 3.41
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 3.4
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 3.4
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 3.37
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 3.35
Total RNA sequencing of APC mutant and wt colonic organoids 3.33
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 3.31
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 3.27
Functional role of SLIT2 and ROBO1 in trophoblasts 3.27
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 3.25
Global analyses of the effect of different cellular contexts on microRNA targeting 3.25
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 3.23
Effect of PBK knockdown on C4-2 cell transcriptome 3.22
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 3.22
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 3.22
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 3.19
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 3.18
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 3.18
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 3.17
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 3.14
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 3.14
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 3.13
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 3.12
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 3.09
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 3.09
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 3.04
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 3.03
Paxillin regulates genomic networks in prostate cancer [C4-2] 3.01
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 2.99
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 2.94
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 2.94
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 2.94
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 2.91
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 2.9
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 2.87
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 2.87
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 2.86
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 2.85
Hepatic transcriptome of pediatric hepatoblastoma. 2.83
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 2.82
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 2.81
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 2.81
Lipid degradation promotes prostate cancer cell survival 2.81
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 2.8
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 2.77
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 2.75
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 2.74
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 2.74
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 2.73
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 2.71
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 2.68
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 2.65
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 2.64
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 2.63
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 2.62
Evolution of a transcriptional regulator from a transmembrane nucleoporin 2.62
RNA-seq in HepG2 and IMR90 cells 2.62
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 2.53
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 2.51
Dilated cardiomyopathy vs Myocarditis 2.49
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 2.48
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 2.46
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 2.46
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 2.45
The Human Testis Cell Atlas via Single-cell RNA-seq 2.43
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 2.42
Primate transcript and protein expression levels evolve under compensatory selection pressures 2.4
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 2.39
Genome-wide transcriptional response to random aneuploidy in human cells 2.39
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 2.39
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 2.38
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 2.37
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 2.37
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 2.33
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 2.33
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 2.32
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 2.32
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 2.32
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 2.31
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 2.31
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 2.31
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 2.29
Identification of global XBP1s target gene expression in human prostate cancer cells 2.28
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 2.28
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 2.28
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 2.28
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 2.28
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 2.25
Hepatitis C virus functionally sequesters miR-122 2.24
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 2.24
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 2.22
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 2.21
Expression data from miR340 overexpressing human A549 cells 2.19
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 2.18
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 2.18
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 2.18
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 2.16
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 2.16
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 2.16
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 2.14
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 2.13
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 2.11
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 2.08
Gene expression signatures of innate lymphoid cells from human blood 2.05
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 2.05
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 2.05
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 2.04
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 2.0
Identification of a LIF-responsive replication-competent human β cell 2.0
Silencing p300 in MCF7 cells to study expression and alternative splicing 1.98
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 1.98
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 1.97
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 1.95
IRF1 regulates IFN dependent and independent gene expression 1.94
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 1.93
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 1.91
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.85
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 1.81
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 1.81
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 1.8
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 1.75
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 1.74
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 1.73
Expression patterns in chronic thromboembolic pulmonary hypertension 1.73
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 1.72
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 1.71
Non-coding regions are the main source of tumor-specific antigens [human] 1.71
Non-coding regions are the main source of tumor-specific antigens 1.71
Single-cell analysis of adult human ovary using 10X genomics 1.7
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 1.67
Discovering human diabetes-risk gene function with genetics and physiological assays 1.65
RNA-Seq in PWS iPSC-derived neurons 1.64
Hepatocyte maturation 1.64
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 1.63
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 1.62
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 1.62
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 1.62
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 1.6
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 1.58
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 1.58
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 1.58
High-efficiency RNA-based reprogramming of human primary fibroblasts 1.57
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 1.56
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 1.55
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 1.53
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 1.52
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 1.52
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 1.52
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 1.52
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.51
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 1.5
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 1.5
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 1.5
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 1.5
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 1.47
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 1.47
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 1.47
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 1.46
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 1.45
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 1.44
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 1.42
Gene expression patterns define the hepatocyte-like cells derived by different strategies 1.42
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 1.42
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 1.39
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 1.38
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 1.37
Gene expression of collecting duct carcinoma of the kidney 1.36
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 1.35
Morphological and molecular characterization of human dermal lymphatic collectors 1.34
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 1.34
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  1.31
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 1.3
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 1.28
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.27
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 1.27
High-resolution comparative analysis of great ape genomes 1.26
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 1.26
Random mono-allelic expression in MECP2-mutated cells 1.22
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 1.21
Identification of long noncoding RNAs regulated by p53 1.2
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.19
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.19
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 1.17
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 1.17
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 1.17
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 1.1
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 1.1
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 1.08
LIN28A modulates splicing and gene expression programs in breast cancer cells 1.08
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 1.06
PRDM1 inhibits proliferation of human colon cancer organoids 1.06
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 1.04
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 1.02
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 1.02
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 1.0
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 1.0
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 0.97
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.97
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 0.96
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 0.95
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 0.92
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 0.91
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 0.9
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.9
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.89
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 0.88
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.88
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 0.86
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 0.82
Transcriptome analysis of BAP1 knockout and restoration 0.82
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 0.82
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.81
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 0.79
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 0.79
Expression by CD133+ cells isolated from the adult human exocrine pancreas 0.79
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 0.77
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 0.75
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 0.75
Characterization of human ILC2 subsets 0.75
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 0.74
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 0.73
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 0.71
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.71
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 0.69
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.68
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.68
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 0.68
Molecular analysis of renal cell carcinoma with unclassfied histology 0.68
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.67
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 0.66
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.66
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 0.65
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 0.65
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 0.63
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 0.63
Gene expression alterations of pancreatic intraepithlial neoplasia 0.63
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.62
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 0.62
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 0.61
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 0.6
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 0.58
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 0.58
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 0.58
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 0.57
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 0.57
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.56
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.55
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 0.54
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.5
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 0.48
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 0.47
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 0.47
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 0.47
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.46
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 0.46
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 0.46
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 0.44
TAF1 is critical for AE driven leukemogenesis 0.41
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 0.41
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 0.38
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.37
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.37
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.37
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 0.36
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.36
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 0.34
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 0.32
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 0.3
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.29
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.28
A single cell reference map for human blood and tissue T cell activation 0.28
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.28
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.28
RNAseq analysis of ruxolitinib treated breast cancers 0.27
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.25
Modeling Human Cancer-induced Cachexia (Human) 0.25
Identification of HOXB13 target genes responsive to BET inhibitors 0.25
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 0.25
ML29755 RNA-seq data 0.24
Repurposing of promoters and enhancers during mammalian evolution 0.24
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 0.22
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.21
BMS-470539 on human synovial fibroblasts 0.21
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.19
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.17
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 0.16
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 0.16
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.13
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.11
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.09
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.08
RNA-Seq and expression data from human adipose tissue 0.08
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.06
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.05
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 0.03
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.03
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 0.01
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation